PF-07055480 (giroctocogene fitelparovec): Recombinant AAV2/6 Human Factor VIII Gene Therapy clinical trials

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

This study is testing a new gene therapy, PF-07055480, for adult men with moderate to severe haemophilia A. It aims to see if this one-time treatment can safely reduce bleeding by helping the body make more of the clotting factor it needs.